Vivianne TorresFelipe OlivaresC FernandezMario CalvoClaudio OrellanaMaritza NavarreteBlaz LesinaMónica FuentesEileen BlackburnGerardo Velásquez2026-03-222026-03-22202310.4067/s0034-98872023000600717https://doi.org/10.4067/s0034-98872023000600717https://andeanlibrary.org/handle/123456789/75198The use of CP in patients hospitalized for moderately severe COVID-19 was not associated with lower mortality, hospital stay, or the need for IMV.esCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMedicineUso de plasma de convalecientes de COVID-19 en pacientes hospitalizados por SARS-CoV-2 de moderada grave-dad en la Región de Los Ríos, Chilearticle